Wichniak Adam, Wierzbicka Aleksandra, Walęcka Małgorzata, Jernajczyk Wojciech
Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957, Warsaw, Poland.
Center for Sleep Medicine, Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957, Warsaw, Poland.
Curr Psychiatry Rep. 2017 Aug 9;19(9):63. doi: 10.1007/s11920-017-0816-4.
The aim of this review article was to summarize recent publications on effects of antidepressants on sleep and to show that these effects not only depend on the kind of antidepressant drugs but are also related to the dose, the time of drug administration, and the duration of the treatment.
Complaints of disrupted sleep are very common in patients suffering from depression, and they are listed among diagnostic criteria for this disorder. Moreover, midnocturnal insomnia is the most frequent residual symptom of depression. Thus, all antidepressants should normalize sleep. However, at least in short-term treatment, many antidepressants with so-called activating effects (e.g. fluoxetine, venlafaxine) may disrupt sleep, while others with sedative properties (e.g., doxepin, mirtazapine, trazodone) rapidly improve sleep, but may cause problems in long-term treatment due to oversedation.For sleep-promoting action, the best effects can frequently be achieved with a very low dose, administered early enough before bedtime and importantly, always as a part of more complex interventions based on the cognitive-behavioral protocol to treat insomnia (CBT-I). For successful treatment of depression, it is necessary to understand the effects of antidepressants on sleep. Each physician should also be aware that some antidepressants may worsen or induce primary sleep disorders like restless legs syndrome, sleep bruxism, REM sleep behavior disorder, nightmares, and sleep apnea, which may result from an antidepressant-induced weight gain.
这篇综述文章旨在总结近期关于抗抑郁药对睡眠影响的出版物,并表明这些影响不仅取决于抗抑郁药物的种类,还与剂量、给药时间和治疗持续时间有关。
睡眠中断的主诉在抑郁症患者中非常常见,并且被列入该疾病的诊断标准之中。此外,午夜失眠是抑郁症最常见的残留症状。因此,所有抗抑郁药都应使睡眠正常化。然而,至少在短期治疗中,许多具有所谓激活作用的抗抑郁药(如氟西汀、文拉法辛)可能会扰乱睡眠,而其他具有镇静特性的药物(如多塞平、米氮平、曲唑酮)能迅速改善睡眠,但长期治疗可能因过度镇静而产生问题。对于促进睡眠的作用,通常以非常低的剂量,在睡前足够早的时间给药,并且重要的是,始终作为基于认知行为疗法治疗失眠(CBT-I)的更复杂干预措施的一部分,这样往往能取得最佳效果。为了成功治疗抑郁症,有必要了解抗抑郁药对睡眠的影响。每位医生还应意识到,一些抗抑郁药可能会加重或诱发原发性睡眠障碍,如不宁腿综合征、磨牙症、快速眼动睡眠行为障碍、噩梦和睡眠呼吸暂停,这些可能是由抗抑郁药导致的体重增加引起的。